Advancements in Chemical Reprogramming

This chapter explores the transformative advancements in stem cell biology, focusing on chemically induced pluripotent stem cells (CiPSCs) and their implications for regenerative medicine. The discussion highlights the transition from genetic approaches to innovative chemical reprogramming techniques, emphasizing their potential for clinical applications and disease modeling. It also addresses the challenges and achievements in generating insulin-producing islet cells from CiPSCs, specifically for treating type 1 diabetes.